News & Articles

A study from the lab of Faraz Bishehsari, MD, PhD, professor in the Department of Internal Medicine at McGovern Medical School at UTHealth Houston, and director of the Gastroenterology Research Center, seeking to develop new methods to personalize treatment for pancreatic ductal adenocarcinoma, has been funded by the National Institutes of Health.

A five-year, $2.8 million grant was awarded to researchers at UTHealth Houston by the National Institutes of Health to evaluate the long-term effects on patients enrolled in the “Cryopreserved Human Umbilical Cord as a Meningeal Patch in Fetoscopic Spina Bifida Repair” trial.

A new oral GLP-1 medication can help adults with obesity and Type 2 diabetes lose more weight and improve their blood sugar levels compared to a placebo, according to findings from the ATTAIN-2 trial led by a UTHealth Houston researcher.

A $100,000 grant awarded to researchers at UTHealth Houston from the John Ritter Foundation will fund an app that will help clinicians recognize, access, and manage thoracic aortic disease.

Evan Cadena was 19 years old when he suffered an ischemic stroke in May 2023. It was the third time a stroke caused him to lose mobility in the right side of his body since he was 16, when doctors in the Rio Grande Valley found an arteriovenous malformation, or AVM, in his brain.

Researchers at UTHealth Houston are examining the biological effects of prenatal cannabis exposure and its potential impact on fetal brain development. Supported by a $3.7 million grant from the National Institutes of Health and the National Institute on Drug Abuse, the study aims to improve screening tools, public health guidance, and prenatal care strategies for pregnant women who use cannabis.

Witten Shane Daniel of Lubbock, Texas, fell seriously ill with the flu in April. When his eyes started twitching and he felt dizzy, his mother, Casey Daniel, suspected that a prolonged fever might be the cause. But as Witten’s symptoms got worse, Casey realized her son’s condition had become a nightmare that would last for several months and require treatment across the state.

A new study led by researchers at UTHealth Houston has brought scientists one step closer to creating a more efficient device that can understand and translate a person’s speech directly from their brain.